Wolverine Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-51,500
Closed -$3.78M 1753
2025
Q3
$3.78M Sell
51,500
-3,800
-7% -$252K 0.03% 417
2025
Q2
$2.88M Buy
+55,300
New +$3.15M 0.03% 454
2024
Q1
Sell
-17,500
Closed -$647K 1769
2023
Q4
$647K Sell
17,500
-400
-2% -$15.1K 0.01% 828
2023
Q3
$684K Hold
17,900
0.01% 803
2023
Q2
$646K Buy
+17,900
New +$611K 0.01% 787
2020
Q4
Sell
-19,300
Closed -$507K 1741
2020
Q3
$507K Sell
19,300
-1,900
-9% -$52.9K ﹤0.01% 733
2020
Q2
$568K Buy
+21,200
New +$478K 0.01% 689

Other funds holding HALO

Wolverine Asset Management's HALO Position: Q4 2025 in Review

Wolverine Asset Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 57,860 shares — an estimated $4.24M sold.

Wolverine Asset Management first reported a position in HALO in Q2 2021 and held it in 2 quarters. The position peaked at $4.24M in Q3 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Wolverine Asset Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 57,860 Halozyme shares in Q4 2025, an estimated $4.24M.
  • Wolverine Asset Management first reported a position in Halozyme in Q2 2021 and held it in 2 quarters.
  • Wolverine Asset Management's Halozyme position peaked at $4.24M in Q3 2025.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.